Posted in | News | Semiconductor | Business

MOSAID License Random Access Memory and Semiconductor Technology

MOSAID Technologies Inc. today announced that it has licensed the Company's patent portfolio to Etron Technology, Inc. of Taiwan, a leading designer and supplier of random access memory and system-on-chip semiconductor products. Under the terms of the agreement, Etron has licensed MOSAID's patent portfolio for a five-year term. Financial details of the license agreement are confidential.

"Etron believes in the importance of protecting intellectual property as a key factor in participating in global markets," said Dr. Nicky Lu, President and CEO, Etron Technology, Inc. "This agreement reflects our respect for the strength of MOSAID's patent portfolio, and their innovative achievements in the DRAM industry."

"We are very pleased to have concluded this license agreement with Etron, which under Dr. Lu's leadership, has emerged as a world-class fabless IC design and product company," said John Lindgren, President and CEO, MOSAID. "As part of the agreement, MOSAID will receive a cross-license to Etron's patents."

"Etron is the first fabless DRAM vendor to license MOSAID's patent portfolio, and the third Taiwanese company to do so," said Michael Vladescu, Vice President, Licensing and Intellectual Property, MOSAID. "We have now signed licenses with 16 companies, representing 80% of global DRAM shipments. We are also expanding our licensing efforts to other industry segments based on our recent exclusive license agreements and patent acquisitions."

MOSAID, a leading intellectual property company, is now focused on patent licensing and technology research and development. The Company is expanding its portfolio of more than 800 patents and applications obtained from internally developed technology, patent licensing partnerships, and patent acquisitions.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.